Harvard Bioscience (HBIO) Reports In-Line Q1 EPS

Harvard Bioscience (NASDAQ: HBIO) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $21.77 million versus the consensus estimate of $20 million.

For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• SpaceX (SPCX) call put ratio 1.1 calls to 1 put
• Cerebras Systems (CBRS) call put ratio 1 call to 1.1 puts into quarter results